1. Home
  2. DSGN vs TITN Comparison

DSGN vs TITN Comparison

Compare DSGN & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSGN
  • TITN
  • Stock Information
  • Founded
  • DSGN 2017
  • TITN 1980
  • Country
  • DSGN United States
  • TITN United States
  • Employees
  • DSGN N/A
  • TITN N/A
  • Industry
  • DSGN Biotechnology: Pharmaceutical Preparations
  • TITN Other Specialty Stores
  • Sector
  • DSGN Health Care
  • TITN Consumer Discretionary
  • Exchange
  • DSGN Nasdaq
  • TITN Nasdaq
  • Market Cap
  • DSGN 348.2M
  • TITN 341.6M
  • IPO Year
  • DSGN 2021
  • TITN 2007
  • Fundamental
  • Price
  • DSGN $4.91
  • TITN $18.14
  • Analyst Decision
  • DSGN Hold
  • TITN Buy
  • Analyst Count
  • DSGN 3
  • TITN 5
  • Target Price
  • DSGN $7.00
  • TITN $19.20
  • AVG Volume (30 Days)
  • DSGN 126.2K
  • TITN 427.0K
  • Earning Date
  • DSGN 03-18-2025
  • TITN 03-20-2025
  • Dividend Yield
  • DSGN N/A
  • TITN N/A
  • EPS Growth
  • DSGN N/A
  • TITN N/A
  • EPS
  • DSGN N/A
  • TITN 1.34
  • Revenue
  • DSGN N/A
  • TITN $2,794,333,000.00
  • Revenue This Year
  • DSGN N/A
  • TITN N/A
  • Revenue Next Year
  • DSGN N/A
  • TITN N/A
  • P/E Ratio
  • DSGN N/A
  • TITN $13.50
  • Revenue Growth
  • DSGN N/A
  • TITN 12.25
  • 52 Week Low
  • DSGN $2.45
  • TITN $12.30
  • 52 Week High
  • DSGN $7.77
  • TITN $27.13
  • Technical
  • Relative Strength Index (RSI)
  • DSGN 53.37
  • TITN 53.71
  • Support Level
  • DSGN $3.58
  • TITN $17.91
  • Resistance Level
  • DSGN $5.17
  • TITN $19.81
  • Average True Range (ATR)
  • DSGN 0.40
  • TITN 0.84
  • MACD
  • DSGN 0.11
  • TITN -0.14
  • Stochastic Oscillator
  • DSGN 83.65
  • TITN 32.93

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

Share on Social Networks: